세계 바이오 기계 시장 : 유형별, 모터 유형별, 용도별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Biological Machines Market is accounted for $4.6 billion in 2023 and is expected to reach $45.3 billion by 2030 growing at a CAGR of 38.4% during the forecast period. Biological machines, also known bio-machines, are sophisticated systems or gadgets that get their design inspiration from or are made of biological elements like cells, proteins, or genetic material. They are intended to carry out certain jobs or functions. These devices are often designed to replicate or use the capacities of living things for a variety of uses, including as industrial, scientific, and medical ones. These devices have the power to transform a number of sectors and advance our knowledge of biology and technology.

Market Dynamics:

Driver:

Integration with existing biological systems

It is possible to create biological devices that smoothly work with current biological functions. They utilize the accuracy and effectiveness of organic biological processes. They are used to administer medications or carry out duties more precisely by focusing on certain cells or tissues in the human body. Biological and synthetic components can be combined to create hybrid devices with improved or novel functionality. These could be more effective biosensors, bio actuators, or biofuel cells than completely synthetic substitutes. These are the elements driving the market's expansion.

Restraint:

Limited control and predictability

Biological systems are naturally complicated and changeable. The behavior of biological machines can be difficult to anticipate and control since it depends on a wide range of variables, such as genetics, environment, and cellular reactions. Furthermore, biological components might deteriorate over time and have a finite lifetime. This restricts biological machines' long-term usefulness and dependability in comparison to conventional mechanical systems, which is limiting market expansion.

Opportunity:

Reduced waste

When compared to conventional industrial methods, biological systems often generate less waste and hazardous byproducts, making them more ecologically friendly. In order to create a variety of goods, including medicines, biofuels, chemicals, and more, these biological machines frequently employ living organisms like bacteria, yeast, or algae. They generate less waste since they are very effective at turning raw materials into the intended product. This may result in lower waste disposal costs and cleaner production methods. This is the element impacting the market's expansion.

Threat:

Safety and containment

Biological machinery is dangerous in terms of containment and safety. There is a chance that genetically modified organisms will be accidentally released, which might have unforeseen ecological effects. Additionally, it's possible that these devices aren't always as energy-efficient as intended. Although biological systems are naturally energy-efficient at the cellular level, the energy needs for maintaining and managing these components when they are incorporated into machines can be substantial. These are the elements preventing further market expansion.

COVID-19 Impact:

Following COVID-19, strict rules were put in place for logistics, and trade channels were shut down. Transporting products from one location to another was hampered by regulations on the supply chain and logistics sector. Sales of local mead, however, increased as a result of the absence of imported goods brought on by travel bans and border closures during the epidemic. Additionally, because pubs and restaurants were closed for extended periods of time, customers were compelled to change their drinking habits. This trend is anticipated to continue because popular drinks like canned wine.

The myosin segment is expected to be the largest during the forecast period

The myosin segment is expected to be the largest during the forecast period. A protein called myosin is essential for many biological functions, including muscle contraction. The term "biological machines" used to describe the myosin-driven molecular motors has multiple benefits. By utilizing chemical energy (ATP) to produce mechanical power and movement, it functions as a molecular motor. Actin filaments move past one another as it "walks" along them, triggering muscle contraction and a number of other cellular functions.

The machine learning segment is expected to have the highest CAGR during the forecast period

The machine learning segment is expected to have the highest CAGR during the forecast period. Biohybrid systems, commonly referred to as biological machines, provide various benefits when using machine learning. These systems mix artificial elements like sensors or controls with biological elements like cells or organisms to provide flexible and adaptable systems. These systems react dynamically to a variety of stimuli thanks to these algorithms' ability to adapt to changing environmental circumstances or needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. There are several biotechnology businesses in this region that strive to create biological machines for a range of uses, including genetic engineering, cell therapy, and drug discovery. The region's universities and research facilities carry out cutting-edge studies in fields relating to biological machines. To progress the field, they frequently work together with business partners and governmental organizations.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Synthetic biology research has been active throughout the region's nations. In this discipline, biological systems, devices, and components are designed and built for a variety of uses, including the generation of biofuel, medicines, and environmental cleanup. The creation of biological devices for use in medicine is a worldwide endeavor. This covers tissue engineering, the production of artificial organs, and the creation of bioactive materials for medical equipment.

Key players in the market:

Some of the key players in Biological Machines market include: Ginkgo Bioworks, Zymergen, Synthace, Codexis, Twist Bioscience, Evonetix, Arzeda, Synthorx, Amyris, Novozymes, Desktop Genetics, Synlogic and Molecular Machines & Industries.

Key Developments:

In November 2022, Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, announced the companies are forming a collaboration to test a new, non-invasive technology in a clinical trial.

In October 2022, Ginkgo Bioworks and Zymergen announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform by integrating strong automation and software capabilities as well as a wealth of experience across diverse biological engineering approaches.

Types Covered:

• Myosin
• Dynein
• Kinesin
• Ribosomes
• Other Types

Motor Types Covered:

• Linear
• Rotary
• Other Motor Types

Applications Covered:

• Biomedical Devices
• Machine Learning
• Biotechnology
• Artificial Intelligence
• Biofuel Production
• Nanotechnology
• Robotics
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Biological Machines Market, By Type

• 5.1 Introduction
• 5.2 Myosin
• 5.3 Dynein
• 5.4 Kinesin
• 5.5 Ribosomes
• 5.6 Other Types

6 Global Biological Machines Market, By Motor Type

• 6.1 Introduction
• 6.2 Linear
  • 6.2.1 Flagella Movement
  • 6.2.2 Muscle Contraction
• 6.3 Rotary
  • 6.3.1 Adenosine Triphosphate(ATP) Hydrolysis
  • 6.3.2 Bacterial Flagellar
  • 6.3.3 Deoxyribonucleic Acid (DNA) Helicases
• 6.4 Other Motor Types

7 Global Biological Machines Market, By Application

• 7.1 Introduction
• 7.2 Biomedical Devices
• 7.3 Machine Learning
• 7.4 Biotechnology
• 7.5 Artificial Intelligence
• 7.6 Biofuel Production
• 7.7 Nanotechnology
• 7.8 Robotics
• 7.9 Other Applications

8 Global Biological Machines Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Ginkgo Bioworks
• 10.2 Zymergen
• 10.3 Synthace
• 10.4 Codexis
• 10.5 Twist Bioscience
• 10.6 Evonetix
• 10.7 Arzeda
• 10.8 Synthorx
• 10.9 Amyris
• 10.10 Novozymes
• 10.11 Desktop Genetics
• 10.12 Synlogic
• 10.1 Molecular Machines & Industries